GT200200245A - Procedimientos para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimientocelularanormal - Google Patents
Procedimientos para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimientocelularanormalInfo
- Publication number
- GT200200245A GT200200245A GT200200245A GT200200245A GT200200245A GT 200200245 A GT200200245 A GT 200200245A GT 200200245 A GT200200245 A GT 200200245A GT 200200245 A GT200200245 A GT 200200245A GT 200200245 A GT200200245 A GT 200200245A
- Authority
- GT
- Guatemala
- Prior art keywords
- procedures
- preparation
- treatment
- regular growth
- bicycle derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000001672 ovary Anatomy 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/027—Organoboranes and organoborohydrides
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A PROCEDIMIENTOS PARA LA PREPARACION DE DERIVADOS BICICLICOS SUSTITUIDOS DE FORMULA GENERAL (I) EN DONDE R1,R3,R4,R5,R11,M,P, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON UTILES EN CASOS DE CRECIMIENTO CELULAR ANORMAL, ESPECIFICAMENTE CANCER DE MAMA, RECTAL, DE ESTOMAGO, OVARIOS, BRONQUIAL, PANCREATICO, ENTRE OTROS DESCRITOS EN LA SOLICITUD.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33464701P | 2001-11-30 | 2001-11-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200200245A true GT200200245A (es) | 2003-09-24 |
Family
ID=23308141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200200245A GT200200245A (es) | 2001-11-30 | 2002-11-28 | Procedimientos para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimientocelularanormal |
Country Status (28)
Country | Link |
---|---|
US (1) | US20030144506A1 (es) |
EP (1) | EP1448551B1 (es) |
JP (1) | JP4220388B2 (es) |
KR (1) | KR20040054813A (es) |
CN (1) | CN1639149A (es) |
AR (1) | AR037591A1 (es) |
AT (1) | ATE377009T1 (es) |
AU (1) | AU2002337428A1 (es) |
BR (1) | BR0214606A (es) |
CA (1) | CA2462149C (es) |
DE (1) | DE60223279T2 (es) |
DO (1) | DOP2002000519A (es) |
ES (1) | ES2295409T3 (es) |
GT (1) | GT200200245A (es) |
HN (1) | HN2002000334A (es) |
HU (1) | HUP0500117A3 (es) |
IL (1) | IL160971A0 (es) |
MX (1) | MXPA04005157A (es) |
PA (1) | PA8558601A1 (es) |
PE (1) | PE20030643A1 (es) |
PL (1) | PL370911A1 (es) |
RS (1) | RS44004A (es) |
RU (1) | RU2004116345A (es) |
SV (1) | SV2004001419A (es) |
TN (1) | TNSN02096A1 (es) |
TW (1) | TW200300691A (es) |
WO (1) | WO2003045939A1 (es) |
ZA (1) | ZA200402054B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004054585A1 (en) * | 2002-12-18 | 2004-07-01 | Pfizer Products Inc. | 4-anilino quinazoline derivatives for the treatment of abnormal cell growth |
BR0317259A (pt) * | 2002-12-19 | 2005-11-08 | Pfizer Prod Inc | Complexos de e-2-metóxi-n-(3-{4-[3-metil-4-(6-metilpiridin-3-ilóxi)-fenil amino]- quinazolin-6-il}-alil)-acetamida, seus métodos de produção e utilização |
WO2004089934A1 (en) * | 2003-04-09 | 2004-10-21 | Pfizer Products Inc. | Processes for the preparation of n-((((pyridinyloxy) -phenylamino) quinazolinyl)- allyl) acetamide derivatives and related compounds as well as intermediates of such processes and processes for the preparation of such intermediates |
US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
WO2005003100A2 (en) * | 2003-07-03 | 2005-01-13 | Myriad Genetics, Inc. | 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
US20050192298A1 (en) * | 2004-02-27 | 2005-09-01 | Pfizer Inc | Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide |
ME01267B (me) | 2004-05-06 | 2013-06-20 | Warner Lambert Co | 4-fenilaminokinazolin-6-ilamidi |
US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
CA2592900A1 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
KR20080082667A (ko) * | 2005-12-02 | 2008-09-11 | 더 페이퍼 프로덕츠 리미티드 | 포장용 홀로그래픽 플렉시블 튜브 라미네이트 및 이의 제조방법 |
BR112021005513A2 (pt) | 2018-09-25 | 2021-06-22 | Black Diamond Therapeutics, Inc. | derivados de quinazolina como inibidor de tirosina quinase, composições, métodos de fabricação e uso dos mesmos |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW321649B (es) * | 1994-11-12 | 1997-12-01 | Zeneca Ltd | |
DE19501481A1 (de) * | 1995-01-19 | 1996-07-25 | Bayer Ag | 2,8-Disubstituierte Chinazolinone |
GB9603095D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
MXPA02012870A (es) * | 2000-06-22 | 2003-05-14 | Pfizer Prod Inc | Derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal. |
-
2002
- 2002-10-03 EP EP02772689A patent/EP1448551B1/en not_active Expired - Lifetime
- 2002-10-03 HU HU0500117A patent/HUP0500117A3/hu unknown
- 2002-10-03 ES ES02772689T patent/ES2295409T3/es not_active Expired - Lifetime
- 2002-10-03 IL IL16097102A patent/IL160971A0/xx unknown
- 2002-10-03 WO PCT/IB2002/004097 patent/WO2003045939A1/en active IP Right Grant
- 2002-10-03 JP JP2003547389A patent/JP4220388B2/ja not_active Expired - Fee Related
- 2002-10-03 RS YU44004A patent/RS44004A/sr unknown
- 2002-10-03 PL PL02370911A patent/PL370911A1/xx unknown
- 2002-10-03 RU RU2004116345/04A patent/RU2004116345A/ru not_active Application Discontinuation
- 2002-10-03 AU AU2002337428A patent/AU2002337428A1/en not_active Abandoned
- 2002-10-03 AT AT02772689T patent/ATE377009T1/de not_active IP Right Cessation
- 2002-10-03 CN CNA028208994A patent/CN1639149A/zh active Pending
- 2002-10-03 DE DE60223279T patent/DE60223279T2/de not_active Expired - Lifetime
- 2002-10-03 BR BR0214606-1A patent/BR0214606A/pt not_active IP Right Cessation
- 2002-10-03 CA CA2462149A patent/CA2462149C/en not_active Expired - Fee Related
- 2002-10-03 MX MXPA04005157A patent/MXPA04005157A/es active IP Right Grant
- 2002-10-03 KR KR10-2004-7008290A patent/KR20040054813A/ko not_active Application Discontinuation
- 2002-11-21 DO DO2002000519A patent/DOP2002000519A/es unknown
- 2002-11-25 PE PE2002001129A patent/PE20030643A1/es not_active Application Discontinuation
- 2002-11-25 PA PA20028558601A patent/PA8558601A1/es unknown
- 2002-11-25 TW TW091134197A patent/TW200300691A/zh unknown
- 2002-11-27 HN HN2002000334A patent/HN2002000334A/es unknown
- 2002-11-28 GT GT200200245A patent/GT200200245A/es unknown
- 2002-11-28 AR ARP020104590A patent/AR037591A1/es unknown
- 2002-11-29 TN TNTNSN02096A patent/TNSN02096A1/en unknown
- 2002-11-29 SV SV2002001419A patent/SV2004001419A/es not_active Application Discontinuation
- 2002-12-02 US US10/307,603 patent/US20030144506A1/en not_active Abandoned
-
2004
- 2004-03-15 ZA ZA200402054A patent/ZA200402054B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ATE377009T1 (de) | 2007-11-15 |
AR037591A1 (es) | 2004-11-17 |
AU2002337428A1 (en) | 2003-06-10 |
TNSN02096A1 (en) | 2005-12-23 |
DE60223279D1 (de) | 2007-12-13 |
HUP0500117A3 (en) | 2008-03-28 |
US20030144506A1 (en) | 2003-07-31 |
HUP0500117A2 (hu) | 2005-05-30 |
PA8558601A1 (es) | 2003-06-30 |
CA2462149C (en) | 2010-06-22 |
CN1639149A (zh) | 2005-07-13 |
JP2005515986A (ja) | 2005-06-02 |
CA2462149A1 (en) | 2003-06-05 |
IL160971A0 (en) | 2004-08-31 |
RS44004A (en) | 2006-10-27 |
DOP2002000519A (es) | 2003-05-31 |
KR20040054813A (ko) | 2004-06-25 |
MXPA04005157A (es) | 2004-08-11 |
DE60223279T2 (de) | 2008-05-29 |
JP4220388B2 (ja) | 2009-02-04 |
RU2004116345A (ru) | 2005-03-27 |
SV2004001419A (es) | 2004-02-24 |
BR0214606A (pt) | 2004-09-14 |
PL370911A1 (en) | 2005-05-30 |
EP1448551A1 (en) | 2004-08-25 |
WO2003045939A1 (en) | 2003-06-05 |
PE20030643A1 (es) | 2003-07-23 |
TW200300691A (en) | 2003-06-16 |
ES2295409T3 (es) | 2008-04-16 |
EP1448551B1 (en) | 2007-10-31 |
HN2002000334A (es) | 2003-02-21 |
ZA200402054B (en) | 2005-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200300296A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
GT200300087A (es) | 2-(2,6-diclorofenil)-diarilimidazoles | |
ECSP066447A (es) | Derivados de isoquinolina 1,4-disustituida como inhibidores raf-quinasa útiles para el tratamiento de enfermedades proliferativas | |
GT200400032A (es) | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transformante (tgf) | |
GT200400274A (es) | Nuevos derivados de quinolina | |
ECSP099817A (es) | Procesos para la preparacion de pirazoles | |
GT200200245A (es) | Procedimientos para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimientocelularanormal | |
EA200801428A1 (ru) | Производные пиридиазинона для лечения опухолей | |
CY1109644T1 (el) | 2,4-διαμινο-πυριμιδινες ως αναστολεις audora | |
GEP20115304B (en) | PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα | |
GT200300289A (es) | Derivados de pirrolopirimidina | |
MA29539B1 (fr) | Procedes de production de derives phenoliques 4-biphenylylazetidin -2-one | |
ECSP088905A (es) | Nuevos compuestos | |
TW200740814A (en) | Compounds | |
TW200510333A (en) | Benzimidazole compounds | |
TN2010000061A1 (en) | Tricyclic bridged cyclopentanedione derivatives as herbicides | |
CR8350A (es) | 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogenica cronica | |
MX2010003365A (es) | Derivados de tiazol para el tratamiento de cancer. | |
TW200738693A (en) | Substituted biaryls, process for their manufacture and use thereof as medicaments | |
EA200801365A1 (ru) | Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины | |
GT200500317A (es) | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
GT200200280A (es) | Lactamas como antagonistas de taquiquininas | |
TW200602326A (en) | Tricyclic imidazopyridines | |
GT200300286A (es) | Derivados biciclicos para el tratamiento del crecimiento celular anormal | |
DE60204701D1 (de) | Tricyclische imidazopyridine |